Loading viewer...
earnings
Format: PDF earnings
VEON's Q3 2023 trading update reports raising full-year revenue and EBITDA guidance while achieving return to USD revenue growth. The presentation covers trading results, business highlights including the completion of exit from Russia, and includes forward-looking statements regarding strategic priorities and market conditions.
earnings
42 Pages
25 Pages
CSAV
Teva Pharmaceutical Q2 2022 Earnings Results
earningsearnings
52 Pages
Teva Pharmaceutical Industries Ltd.
Helios Technologies Q3 2023 Earnings Presentation
earningsearnings
29 Pages
Helios Technologies
Observe Medical H1 2024 Earnings Presentation
earningsearnings
16 Pages
Observe Medical ASA